Open-Label Study of Clarithromycin in Patients with Undifferentiated Connective Tissue Disease

Clarithromycin, a macrolide antibiotic, led to clinical improvement in patients with UCTD. Efficacy and safety data support further investigation of macrolide antibiotic use as a primary or adjunctive treatment in various connective tissue diseases.